Global Angiotensin II Inhibitors with Calcium Channel Blockers Market: Overview
Angiotensin II inhibitors with calcium channel blockers are combination drugs that contain a calcium channel blocker and an angiotensin II inhibitor. These are used in the treatment of high blood pressure (hypertension). angiotensin II inhibitors with calcium channel blockers help in stopping the activation of the angiotensin II receptor that result in decreased vasopressin, decreased production of aldosterone, and vasodilation. The blood pressure decreases due to these effects. Entry of calcium into the walls of the smooth muscle in the blood vessels, and cells of the heart results in decrease of aldosterone production, slowing of heart rate, reduction in heart contraction force, and vasodilation of arteries. As a result of these effects, in patients with ischemic heart disease or angina, there is reduction in the symptoms, and in the patients with hypertension there is reduction of blood pressure due to the use of angiotensin II inhibitors with calcium channel blocking drugs.
Hypertension (high or raised blood pressure or HBP) is caused due to rapid blood flow through the blood vessels. The heart has to pump blood harder if blood pressure is high.
Global Angiotensin II Inhibitors with Calcium Channel Blockers Market: Drivers and Restraints
Poor management of stress, alcohol addiction, lack of exercise, and rise in physical inactivity propel the angiotensin II inhibitors with calcium channel blockers market. Rise in prevalence of cardiovascular diseases boosts the growth of the angiotensin II inhibitors with calcium channel blockers market. According to the World Health Organization, large population in middle- and low- income countries is affected by cardiovascular diseases. Increase in geriatric population leads to high prevalence of hypertension which in turn propels the angiotensin II inhibitors with calcium channel blockers market. According to the WHO, complications of hypertension account for approximately 9.4 million deaths globally each year.
Global Angiotensin II Inhibitors with Calcium Channel Blockers Market: Key Segments
The global angiotensin II inhibitors with calcium channel blockers market can be segmented based on disease type, distribution channel, and region. In terms of disease type, the angiotensin II inhibitors with calcium channel blockers market can be classified into heart disease, angina, and hypertension. Based on distribution channel, the global angiotensin II inhibitors with calcium channel blockers market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies.
Geographically, the global angiotensin II inhibitors with calcium channel blockers market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest angiotensin II inhibitors with calcium channel blockers market share in 2016, due to high prevalence of high blood pressure. According to the World Health Organization, 20% to 40% of the adult population, around 250 million people, in North America are affected by high blood pressure. Europe held the second largest market share in 2016 due to increase in geriatric population. The geriatric population is more prone to the high blood pressure disease. According to Eurostat statistics, in 2016, the geriatric population accounted for 19.2% of the population of Europe. The angiotensin II inhibitors with calcium channel blockers market in Asia Pacific is anticipated to grow rapidly during the forecast period due to rise in prevalence of high blood pressure among the population. According to the WHO, high prevalence of high blood pressure is due to limited access to treatment and delays in diagnosis that result in poor health outcomes. These factors drive the angiotensin II inhibitors with calcium channel blockers market in the region. The angiotensin II inhibitors with calcium channel blockers market in Latin America and Middle East & Africa is expected to witness exponential growth during the forecast period due to increase in government initiatives in the health care sector.
Global Angiotensin II Inhibitors with Calcium Channel Blockers Market: Key Players
Key players in the global angiotensin II inhibitors with calcium channel blockers market include Boehringer Ingelheim International GmbH, Daiichi Sankyo, Inc., and Novartis AG.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.